IMPOWER010: Characterization of Stage Ib-Iiia Nsclc Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
AuthID
P-00V-NH4
P-00V-NH4
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service